Rheumatology

Research Faculty

Division HeadHide

Hermine I. Brunner, MD, MSc, MBA Director, Division of Rheumatology

Hermine I. Brunner, MD, MSc, MBA, is a pediatric rheumatologist with a special interest in clinical and translational research, focusing on pediatric lupus. Her research is focused on biomarker discovery for children with lupus and the testing of new medications for various pediatric rheumatic diseases. Dr. Brunner is also involved in trial design and provides statistical support at Cincinnati Children's and is pioneering the development of outcome measures and improving the quality of care for children with lupus and other pediatric rheumatic diseases.

Visit the Brunner Research Lab.

513-636-6320 hermine.brunner@cchmc.org

FacultyShow

Sheila T. Angeles-Han, MD, MSc Physician, Division of Rheumatology

Dr. Han’s clinical and research career is dedicated to improving the visual outcomes of children with chronic non-infectious uveitis by decreasing vision loss and blindness in this population. Her research efforts focus on discovering and validating biomarkers for uveitis in children with JIA, and developing a comprehensive outcomes assessment protocol for pediatric inflammatory eye disease. She also has experience in questionnaire development and validated the only measure of vision vision-related quality of life and function for pediatric uveitis, the “Effects of Youngsters' Eyesight on Quality of Life” (EYE-Q).

513-636-4676 sheila.angeles-han@cchmc.org

Alexei A. Grom, MD Research Director, Division of Rheumatology

Alexei A. Grom, MD, is a pediatric rheumatologist with a special interest in the pathways associated with the development of macrophage activation syndrome, a life-threatening complication of systemic juvenile idiopathic arthritis (SJIA). His work includes a strong translational component; along with studying the mechanisms behind these conditions, his lab is researching potential biomarkers that could facilitate early diagnosis and treatment.
Visit the Grom-Thornton Research Lab.

513-636-3339 alexei.grom@cchmc.org

Michael Henrickson, MD, MPH, RhMSUS Director of Telemedicine, Division of Rheumatology

Michael Henrickson, MD, MPH, participates in numerous ongoing clinical research trials, as a feature of the Division of Rheumatology's translational research focus.

513-636-4676 michael.henrickson@cchmc.org

Jennifer L. Huggins, MD Fellowship Program Director, Division of Rheumatology

513-803-0649 jennifer.huggins@cchmc.org

Daniel J. Lovell, MD, MPH Associate Director, Division of Rheumatology

Daniel J. Lovell, MD, MPH, focuses on the performance of interventional clinical trials in children with juvenile idiopathic arthritis (JIA) and other rheumatic diseases. He has served as the PI for >30 multicenter, interventional trials in JIA. Dr. Lovell is also involved in the development and validation of outcome measures and clinical response definitions for JIA, JDM and childhood onset systemic lupus erythematosus (SLE).

513-636-4676 daniel.lovell@cchmc.org

Esi M. Morgan, MD, MSCE Clinical Director, Division of Rheumatology

Esi Morgan, MD, MSCE, focuses on the development and validation of patient reported outcomes measures using modern psychometric approaches, including item response theory, for improved health assessment in children. A second major research focus concerns improving clinical outcomes of patients with juvenile idiopathic arthritis through the science of quality improvement.

513-803-2672 kathy.weber@cchmc.org

Grant Schulert, MD, PhD

Grant Schulert, MD, PhD, is focused on mechanisms of innate immunity and inflammation, specifically as they relate to rheumatic diseases in children. In particular he investigates the function and regulation of monocytes and macrophages during systemic inflammation. He also focuses on use of genomic approaches to define the risk for systemic inflammatory diseases.
Visit the Schulert Research Lab.

513-636-4676 grant.schulert@cchmc.org

Sherry L. Thornton, PhD

Sherry L. Thornton, PhD, research focuses on finding and functionally evaluating targets for the treatment of rheumatic disease, with a particular interest in the role of angiogenesis in human arthritis and animal models of arthritis. A second interest is the use of reagents to label inflammatory cells for visualization during arthritis as a potential clinical tool, and for evaluation of cell types during the course of disease in animal models.
Visit the Grom/Thornton Lab.

513-636-1318 sherry.thornton@cchmc.org

Tracy V. Ting, MD, MSc, RhMSUS

513-636-4676

Patricia Vega Fernandez, MD, MSc, RhMSUS

513-636-4676 patricia.vegafernandez@cchmc.org

Rheumatology

Research Faculty

Connect With Us